Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Head and Neck Cancers
•
Radiation Oncology
When using hyperfractionation with a BID regimen, what are typical dose constraints for the head and neck?
Answer from: Radiation Oncologist at Academic Institution
Similar to 2 Gy once daily with a little more wiggle room
Sign In
or
Register
to read more
17721
Related Questions
Would you recommend adjuvant radiation for a patient with head/neck merkel cell carcinoma following a pathologic complete response to neoadjuvant immunotherapy?
How would you approach post-op radiation recommendations in patients who had neoadjuvant chemoimmunotherapy for HPV mediated OPSCC s/p TORS who have a complete pathologic response (pCR)?
For a patient with a salivary gland tumor with evidence of local recurrence would you recommend 6 weekly fractions if giving RT alone?
What would your approach be for a locally advanced head and neck cancer diagnosed concurrently with a mid-esophageal cancer?
How would the updated results of ECOG 3311 influence your adjuvant RT recommendations for HPV+ OPSCC?
Is there a scenario in which you would consider observation for T4a SCC involving the mandible?
How do you approach cisplatin dosing for locally advanced head and neck SCC in HPV-positive and HPV-negative patients?
What are your top takeaways in Head & Neck Cancers from ASCO 2025?
What is the preferred neoadjuvant/adjuvant chemotherapy regimen for HPV-associated nasopharyngeal cancer?
How would you approach a patient with a carotid body tumor and metastasis to the cervical lymph node?